Through detailed electronic health records analysis, researchers at Vanderbilt University Medical Center may have found a new and efficient method for uncovering drug benefits and for drawing more informative repurposing predictions.

In particular, VUMC officials contend that their study lends new plausibility to the hypothesis that metformin, a diabetes drug that patients generally find easy to tolerate, might have use in treating at least some types of cancer.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access